Literature DB >> 33264494

Circular RNA hsa_circ_0000658 inhibits osteosarcoma cell proliferation and migration via the miR-1227/IRF2 axis.

Xin Jiang1, Dong Chen1.   

Abstract

Osteosarcoma (OS) is the most frequently occurring bone cancer. Circular RNAs (circRNAs) have been shown to exert pivotal impact in modulation of gene expression, but their roles in OS are still not fully understood. In this study, we analysed the role of circ-0000658 in OS. Thereafter, molecular techniques such as Western blot, qRT-PCR, RNA-binding protein immunoprecipitation and Dual-Luciferase reporter assays were implemented to investigate the role of circ-0000658/miR-1227/interferon regulatory factor-2 (IRF2) axis in OS. Eventually, the impact of circ-0000658 on tumour growth and metastasis was observed in a xenograft mouse model. The results of this study revealed that circ-0000658 exhibits low levels in OS tissues and cell lines. Moreover, circ-0000658 repression promoted cell cycle, proliferation, invasion and migration but inhibited the apoptosis of OS cells. Researches have previously shown that circ-0000658 contains a binding site for miR-1227 and thus can abundantly sponge miR-1227 to up-regulate the expression of its target gene IRF2. Moreover, both inhibition of miR-1227 and overexpression of IRF2 reversed cell proliferation and invasion, which was triggered by circ-0000658 repression. Conclusively, circ-0000658 modulates biological function of OS cells through the miR-1227/IRF2 axis. Therefore, circ-0000658 might act as a possible novel therapeutic target for the treatment of OS.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990circ-0000658zzm321990; IRF2; circRNA; miR-1227; osteosarcoma

Year:  2020        PMID: 33264494     DOI: 10.1111/jcmm.16105

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  7 in total

Review 1.  Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis.

Authors:  Jingyu Zhong; Guangcheng Zhang; Weiwu Yao
Journal:  J Orthop Surg Res       Date:  2021-10-07       Impact factor: 2.359

2.  Overexpression of Circular RNA circ_0013587 Reverses Erlotinib Resistance in Pancreatic Cancer Cells Through Regulating the miR-1227/E-Cadherin Pathway.

Authors:  Huiting Xu; Runzhi Chen; Qian Shen; Dongmei Yang; Hui Peng; Jin Tong; Qiang Fu
Journal:  Front Oncol       Date:  2021-09-06       Impact factor: 6.244

3.  Hsa_circ_0001017 promotes cell proliferation, migration and invasion in osteosarcoma by sponging miR-145-5p.

Authors:  Qinglei Yang; Hongying Yu; Konghe Hu
Journal:  J Orthop Surg Res       Date:  2022-03-28       Impact factor: 2.359

4.  Screening differential circular RNA expression profiles reveals the regulatory role of circMARS in anti-tuberculosis drug-induced liver injury.

Authors:  Biao Li; Qi Ren; Yuhong Li; Shenqian Tian; Yingzhi Chong; Shufeng Sun; Fumin Feng
Journal:  J Cell Mol Med       Date:  2022-01-14       Impact factor: 5.310

5.  Hsa_circ_0001982 promotes the proliferation, invasion, and multidrug resistance of osteosarcoma cells.

Authors:  Bochuan Lin; Jing Nan; Kai Lu; Yi Zong; Wencan Fan
Journal:  J Clin Lab Anal       Date:  2022-05-16       Impact factor: 3.124

6.  IRF2 Destabilizes Oncogenic KPNA2 to Modulate the Development of Osteosarcoma.

Authors:  Shuchi Xia; Yiqun Ma
Journal:  J Oncol       Date:  2022-09-26       Impact factor: 4.501

7.  A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA-324-5p/cyclin-dependent kinase 16 axis.

Authors:  Ji-An Zhao; Wenjia Nie; Liang Dong; Wencong Liu; Wei Wei
Journal:  J Gastroenterol Hepatol       Date:  2021-06-03       Impact factor: 4.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.